in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (4 days ago)
#SaferWorldbyDesign Use of alternative skin models for animal-free safety and efficacy testing in dermatology resea… https://t.co/I9wkhBRjZm
Edelweiss Connect (4 days ago)
RT @barryhardy: The activities of drug inactive ingredients on biological targets This #OpenTox Webinar (Thursday 8 August) will include a…
Edelweiss Connect (3 weeks ago)
#SaferWorldbyDesign webinar presented by @Scivera Tuesday, July 28 at 16 CEST/10am EDT Exploring and selecting sa… https://t.co/zZglASzWX9
Edelweiss Connect (2 months ago)
Join us Tuesday (16 CEST, 10 am EDT) for this week's SaferWorldbyDesign webinar presented by @InSphero A Novel Fr… https://t.co/u6LuVH9d5w
Edelweiss Connect (3 months ago)
Join us Tuesday at 16 CEST/10 EDT for webinar & discussion on using COVID-19 data with EdelweissData™ #Covid_19… https://t.co/TXmUIh2gCi

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA